Avior Bio
Holly Springs
About Avior Bio
Avior Bio is a clinical-stage, pharmaceutical company developing drugs for distressed neurological conditions. Using its disruptive drug delivery technology – Speedit™ Transmucosal Film Technology – we are positioned to develop products that bring unsurpassed value in efficacy and safety. Avior has an excellent management team, a strong advisory board, supportive partners, dedicated scientists, and knowledgeable clinicians that position us to be successful.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $956.0K
- Last round: Debt Financing (Feb 2023)
- Website: aviorbio.com
- Phone: (919) 285- 3703
Industries & Categories
Biotechnology, Neuroscience, Pharmaceutical, Product Design
Social Profiles
Canonical: https://fsome.com/organization/avior-bio-103254 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.